{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/IRON/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-10T11:44:51.729Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9484,"canonical_name":"Disc Medicine, Inc.","cik":"0001816736","uei":null,"lei":null,"duns":null,"ticker":"IRON"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":51,"clinical":4},"count":55,"timeline":[{"ts":"2026-09-11","kind":"sec.form144","reporter":"KEVIN J BITTERMAN","title":"Officer","shares":27136,"usd_value":1902505,"security_title":"Common","approx_sale_date":"2026-09-11","accession_number":"0001950047-26-009330","importance":40.380500992},{"ts":"2026-09-11","kind":"sec.filing","form_type":"144","title":"144 — Bitterman Kevin — 2026-09-11","url_slug":"/sec/cik-0001591747/144/0001950047-26-009330","accession_number":"0001950047-26-009330","importance":30},{"ts":"2026-07-13","kind":"sec.form144","reporter":"JOHN QUISEL","title":"Director, Officer","shares":33000,"usd_value":2527470,"security_title":"Common","approx_sale_date":"2026-07-13","accession_number":"0001950047-26-007036","importance":40.505494},{"ts":"2026-07-13","kind":"sec.insider.s","reporter":"Quisel John D","title":"Chief Executive Officer","shares":16896,"price_per_share":74.9469,"usd_value":1266303,"security_title":"Common Stock","importance":36.2663028224},{"ts":"2026-07-13","kind":"sec.insider.s","reporter":"Quisel John D","title":"Chief Executive Officer","shares":9704,"price_per_share":74.2729,"usd_value":720744,"security_title":"Common Stock","importance":35.7207442216},{"ts":"2026-07-13","kind":"sec.insider.s","reporter":"Quisel John D","title":"Chief Executive Officer","shares":6400,"price_per_share":76.052,"usd_value":486733,"security_title":"Common Stock","importance":35.4867328},{"ts":"2026-07-13","kind":"sec.insider.m","reporter":"Quisel John D","title":"Chief Executive Officer","shares":25584,"price_per_share":9.86,"usd_value":252258,"security_title":"Common Stock","importance":15.25225824},{"ts":"2026-07-13","kind":"sec.insider.m","reporter":"Quisel John D","title":"Chief Executive Officer","shares":7416,"price_per_share":13.5,"usd_value":100116,"security_title":"Common Stock","importance":15.100116},{"ts":"2026-07-09","kind":"sec.filing","form_type":"4","title":"4 — Disc Medicine, Inc. — 2026-07-09","url_slug":"/sec/cik-0001816736/4/0001193125-26-299954","accession_number":"0001193125-26-299954","importance":30},{"ts":"2026-07-07","kind":"sec.form144","reporter":"JONATHAN YU","title":"Officer","shares":10000,"usd_value":770100,"security_title":"Common","approx_sale_date":"2026-07-07","accession_number":"0001950047-26-006921","importance":40.15402},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Yu Jonathan Yen-Wen","title":"Chief Operating Officer","shares":100,"price_per_share":82.5,"usd_value":8250,"security_title":"Common Stock","importance":35.00825},{"ts":"2026-07-07","kind":"sec.filing","form_type":"144","title":"144 — Disc Medicine, Inc. — 2026-07-07","url_slug":"/sec/cik-0001816736/144/0001950047-26-006921","accession_number":"0001950047-26-006921","importance":30},{"ts":"2026-07-07","kind":"sec.insider.m","reporter":"Yu Jonathan Yen-Wen","title":"Chief Operating Officer","shares":100,"price_per_share":13.5,"usd_value":1350,"security_title":"Common Stock","importance":15.00135},{"ts":"2026-06-30","kind":"sec.filing","form_type":"8-K","title":"8-K — Disc Medicine, Inc. — 2026-06-30","url_slug":"/sec/cik-0001816736/8-k/0001193125-26-290542","accession_number":"0001193125-26-290542","importance":35},{"ts":"2026-06-30","kind":"sec.filing","form_type":"4","title":"4 — Disc Medicine, Inc. — 2026-06-30","url_slug":"/sec/cik-0001816736/4/0001193125-26-290891","accession_number":"0001193125-26-290891","importance":30},{"ts":"2026-06-30","kind":"sec.filing","form_type":"4","title":"4 — Disc Medicine, Inc. — 2026-06-30","url_slug":"/sec/cik-0001816736/4/0001193125-26-290902","accession_number":"0001193125-26-290902","importance":30},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Khara Rahul","title":"Chief Legal Officer","shares":1649,"price_per_share":75,"usd_value":123675,"security_title":"Common Stock","importance":35.123675},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"Khara Rahul","title":"Chief Legal Officer","shares":1649,"price_per_share":14.69,"usd_value":24224,"security_title":"Common Stock","importance":15.02422381},{"ts":"2026-06-26","kind":"sec.form144","reporter":"RAHUL KHARA","title":"Officer","shares":2500,"usd_value":175400,"security_title":"Common","approx_sale_date":"2026-06-26","accession_number":"0001950047-26-006558","importance":40.03508},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Khara Rahul","title":"Chief Legal Officer","shares":851,"price_per_share":75,"usd_value":63825,"security_title":"Common Stock","importance":35.063825},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Yu Jonathan Yen-Wen","title":"Chief Operating Officer","shares":300,"price_per_share":72.5,"usd_value":21750,"security_title":"Common Stock","importance":35.02175},{"ts":"2026-06-26","kind":"sec.filing","form_type":"144","title":"144 — Disc Medicine, Inc. — 2026-06-26","url_slug":"/sec/cik-0001816736/144/0001950047-26-006558","accession_number":"0001950047-26-006558","importance":30},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"Khara Rahul","title":"Chief Legal Officer","shares":851,"price_per_share":14.69,"usd_value":12501,"security_title":"Common Stock","importance":15.01250119},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"Yu Jonathan Yen-Wen","title":"Chief Operating Officer","shares":300,"price_per_share":13.5,"usd_value":4050,"security_title":"Common Stock","importance":15.00405},{"ts":"2026-06-24","kind":"sec.filing","form_type":"8-K","title":"8-K — Disc Medicine, Inc. — 2026-06-24","url_slug":"/sec/cik-0001816736/8-k/0001193125-26-281096","accession_number":"0001193125-26-281096","importance":35},{"ts":"2026-06-24","kind":"sec.filing","form_type":"4","title":"4 — Disc Medicine, Inc. — 2026-06-24","url_slug":"/sec/cik-0001816736/4/0001193125-26-281519","accession_number":"0001193125-26-281519","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"4","title":"4 — Quisel John D — 2026-06-23","url_slug":"/sec/cik-0001586788/4/0001193125-26-279779","accession_number":"0001193125-26-279779","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"4","title":"4 — Disc Medicine, Inc. — 2026-06-23","url_slug":"/sec/cik-0001816736/4/0001193125-26-279732","accession_number":"0001193125-26-279732","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"4","title":"4 — Disc Medicine, Inc. — 2026-06-23","url_slug":"/sec/cik-0001816736/4/0001193125-26-279792","accession_number":"0001193125-26-279792","importance":30},{"ts":"2026-06-22","kind":"sec.form144","reporter":"JONATHAN YU","title":"Officer","shares":10000,"usd_value":707900,"security_title":"Common","approx_sale_date":"2026-06-22","accession_number":"0001950047-26-006384","importance":40.14158},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"Yu Jonathan Yen-Wen","title":"Chief Operating Officer","shares":9700,"price_per_share":72.6593,"usd_value":704795,"security_title":"Common Stock","importance":35.70479521},{"ts":"2026-06-22","kind":"sec.filing","form_type":"144","title":"144 — Disc Medicine, Inc. — 2026-06-22","url_slug":"/sec/cik-0001816736/144/0001950047-26-006384","accession_number":"0001950047-26-006384","importance":30},{"ts":"2026-06-22","kind":"sec.insider.m","reporter":"Yu Jonathan Yen-Wen","title":"Chief Operating Officer","shares":9700,"price_per_share":13.5,"usd_value":130950,"security_title":"Common Stock","importance":15.13095},{"ts":"2026-06-18","kind":"sec.form144","reporter":"JOHN QUISEL","title":"Director, Officer","shares":34000,"usd_value":2387140,"security_title":"Common","approx_sale_date":"2026-06-18","accession_number":"0001950047-26-006325","importance":40.477428},{"ts":"2026-06-18","kind":"sec.form144","reporter":"RAHUL KHARA","title":"Officer","shares":7500,"usd_value":526575,"security_title":"Common","approx_sale_date":"2026-06-18","accession_number":"0001950047-26-006324","importance":40.105315},{"ts":"2026-06-18","kind":"sec.insider.s","reporter":"Quisel John D","title":"Chief Executive Officer","shares":22927,"price_per_share":69.9184,"usd_value":1603019,"security_title":"Common Stock","importance":36.6030191568},{"ts":"2026-06-18","kind":"sec.insider.s","reporter":"Quisel John D","title":"Chief Executive Officer","shares":9522,"price_per_share":70.7,"usd_value":673205,"security_title":"Common Stock","importance":35.6732054},{"ts":"2026-06-18","kind":"sec.insider.s","reporter":"Khara Rahul","title":"Chief Legal Officer","shares":5400,"price_per_share":69.9423,"usd_value":377688,"security_title":"Common Stock","importance":35.37768842},{"ts":"2026-06-18","kind":"sec.insider.s","reporter":"Khara Rahul","title":"Chief Legal Officer","shares":1600,"price_per_share":70.7257,"usd_value":113161,"security_title":"Common Stock","importance":35.11316112},{"ts":"2026-06-18","kind":"sec.insider.s","reporter":"Quisel John D","title":"Chief Executive Officer","shares":1551,"price_per_share":71.6126,"usd_value":111071,"security_title":"Common Stock","importance":35.1110711426},{"ts":"2026-06-18","kind":"sec.insider.s","reporter":"Khara Rahul","title":"Chief Legal Officer","shares":500,"price_per_share":71.622,"usd_value":35811,"security_title":"Common Stock","importance":35.035811},{"ts":"2026-06-18","kind":"sec.filing","form_type":"144","title":"144 — Disc Medicine, Inc. — 2026-06-18","url_slug":"/sec/cik-0001816736/144/0001950047-26-006324","accession_number":"0001950047-26-006324","importance":30},{"ts":"2026-06-18","kind":"sec.filing","form_type":"4","title":"4 — Disc Medicine, Inc. — 2026-06-18","url_slug":"/sec/cik-0001816736/4/0001193125-26-275996","accession_number":"0001193125-26-275996","importance":30},{"ts":"2026-06-18","kind":"sec.insider.m","reporter":"Quisel John D","title":"Chief Executive Officer","shares":34000,"price_per_share":9.86,"usd_value":335240,"security_title":"Common Stock","importance":15.33524},{"ts":"2026-06-18","kind":"sec.insider.m","reporter":"Khara Rahul","title":"Chief Legal Officer","shares":7500,"price_per_share":14.69,"usd_value":110175,"security_title":"Common Stock","importance":15.110175},{"ts":"2026-06-16","kind":"sec.form144","reporter":"JONATHAN YU","title":"Officer","shares":18612,"usd_value":1304515,"security_title":"Common","approx_sale_date":"2026-06-16","accession_number":"0001950047-26-006217","importance":40.260903016},{"ts":"2026-06-16","kind":"sec.insider.s","reporter":"Yu Jonathan Yen-Wen","title":"Chief Operating Officer","shares":11651,"price_per_share":68.7582,"usd_value":801102,"security_title":"Common Stock","importance":35.8011017882},{"ts":"2026-06-16","kind":"sec.insider.s","reporter":"Yu Jonathan Yen-Wen","title":"Chief Operating Officer","shares":6961,"price_per_share":69.918,"usd_value":486699,"security_title":"Common Stock","importance":35.486699198},{"ts":"2026-06-16","kind":"sec.filing","form_type":"144","title":"144 — Disc Medicine, Inc. — 2026-06-16","url_slug":"/sec/cik-0001816736/144/0001950047-26-006217","accession_number":"0001950047-26-006217","importance":30},{"ts":"2026-06-16","kind":"sec.insider.m","reporter":"Yu Jonathan Yen-Wen","title":"Chief Operating Officer","shares":13351,"price_per_share":9.86,"usd_value":131641,"security_title":"Common Stock","importance":15.13164086},{"ts":"2026-06-16","kind":"sec.insider.m","reporter":"Yu Jonathan Yen-Wen","title":"Chief Operating Officer","shares":5261,"price_per_share":9.86,"usd_value":51873,"security_title":"Common Stock","importance":15.05187346},{"ts":"2026-05-13","kind":"clinical.trial","reporter":"Disc Medicine, Inc","title":"Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia","security_title":"PHASE1,PHASE2","status":"RECRUITING","accession_number":"NCT05320198","excerpt":"[\"Myelofibrosis; Anemia\",\"Anemia\",\"Myelofibrosis\",\"Myelofibrosis Due to and Following Polycythemia Vera\",\"Primary Myelofibrosis\",\"Post-essential Thrombocythemia Myelofibrosis\",\"Myelodysplastic Syndromes\"]","importance":45},{"ts":"2026-05-12","kind":"clinical.trial","reporter":"Disc Medicine, Inc","title":"A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07187973","excerpt":"[\"Sickle Cell Disease\"]","importance":30},{"ts":"2026-05-07","kind":"clinical.trial","reporter":"Disc Medicine, Inc","title":"Study of Bitopertin in Participants With EPP or XLP (APOLLO)","security_title":"PHASE3","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT06910358","excerpt":"[\"Erythropoietic Protoporphyria (EPP)\",\"X-Linked Protoporphyria (XLP)\"]","importance":60},{"ts":"2026-04-22","kind":"clinical.trial","reporter":"Disc Medicine, Inc","title":"Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia","security_title":"PHASE1","status":"COMPLETED","accession_number":"NCT05745883","excerpt":"[\"Chronic Kidney Diseases\",\"Anemia of Chronic Kidney Disease\"]","importance":30}]}